4 months Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks

The FDA’s nod is based on late-stage data, which show that treatment with VRTX’s Alyftrek enhances patient benefit compared to the blockbuster drug Trikafta.